参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/01/30 | 1,530 | 1,530 | 1,495.5 | 1,500.5 | +20.5 | +1.4% | 981,500 |
2024/01/29 | 1,486.5 | 1,488 | 1,476 | 1,480 | +8.5 | +0.6% | 457,800 |
2024/01/26 | 1,475 | 1,482.5 | 1,471 | 1,471.5 | -1.5 | -0.1% | 828,300 |
2024/01/25 | 1,494 | 1,494 | 1,464.5 | 1,473 | -25 | -1.7% | 917,500 |
2024/01/24 | 1,514 | 1,534 | 1,498 | 1,498 | -16 | -1.1% | 932,300 |
2024/01/23 | 1,497 | 1,527 | 1,495 | 1,514 | +37.5 | +2.5% | 1,101,100 |
2024/01/22 | 1,479.5 | 1,495 | 1,472 | 1,476.5 | +10.5 | +0.7% | 769,600 |
2024/01/19 | 1,487.5 | 1,492 | 1,456.5 | 1,466 | -21.5 | -1.4% | 934,300 |
2024/01/18 | 1,489.5 | 1,489.5 | 1,476 | 1,487.5 | -2.5 | -0.2% | 671,600 |
2024/01/17 | 1,494.5 | 1,509.5 | 1,482.5 | 1,490 | ±0 | ±0% | 1,469,500 |
2024/01/16 | 1,490 | 1,499.5 | 1,484.5 | 1,490 | +0.5 | ±0% | 764,000 |
2024/01/15 | 1,480 | 1,490.5 | 1,459.5 | 1,489.5 | +16.5 | +1.1% | 785,800 |
2024/01/12 | 1,477.5 | 1,482.5 | 1,464.5 | 1,473 | +15.5 | +1.1% | 945,300 |
2024/01/11 | 1,482.5 | 1,482.5 | 1,454 | 1,457.5 | -16.5 | -1.1% | 1,014,600 |
2024/01/10 | 1,455 | 1,479.5 | 1,446 | 1,474 | +24 | +1.7% | 1,164,900 |
2024/01/09 | 1,431 | 1,462 | 1,422.5 | 1,450 | +28.5 | +2% | 945,900 |
2024/01/05 | 1,434.5 | 1,437 | 1,401.5 | 1,421.5 | -12 | -0.8% | 1,308,700 |
2024/01/04 | 1,409.5 | 1,434 | 1,397.5 | 1,433.5 | +28.5 | +2% | 1,194,400 |
2023/12/29 | 1,400 | 1,405 | 1,392 | 1,405 | +4 | +0.3% | 779,300 |
2023/12/28 | 1,382 | 1,401 | 1,380.5 | 1,401 | +8.5 | +0.6% | 560,900 |
2023/12/27 | 1,380 | 1,402 | 1,375 | 1,392.5 | +8 | +0.6% | 856,000 |
2023/12/26 | 1,392 | 1,392 | 1,374.5 | 1,384.5 | -10.5 | -0.8% | 612,300 |
2023/12/25 | 1,425 | 1,439 | 1,390 | 1,395 | -5.5 | -0.4% | 963,600 |
2023/12/22 | 1,380 | 1,401 | 1,377 | 1,400.5 | +24 | +1.7% | 797,100 |
2023/12/21 | 1,390 | 1,397.5 | 1,372 | 1,376.5 | -3.5 | -0.3% | 833,700 |
2023/12/20 | 1,387.5 | 1,404.5 | 1,374.5 | 1,380 | +0.5 | ±0% | 1,286,500 |
2023/12/19 | 1,378.5 | 1,388 | 1,366.5 | 1,379.5 | +4.5 | +0.3% | 1,609,100 |
2023/12/18 | 1,361.5 | 1,376 | 1,345 | 1,375 | +41 | +3.1% | 1,921,800 |
2023/12/15 | 1,397 | 1,404.5 | 1,315.5 | 1,334 | -66.5 | -4.7% | 5,852,100 |
2023/12/14 | 1,400 | 1,410.5 | 1,384 | 1,400.5 | +1.5 | +0.1% | 1,497,600 |
2023/12/13 | 1,412 | 1,415 | 1,397.5 | 1,399 | -2 | -0.1% | 938,900 |
2023/12/12 | 1,391 | 1,405 | 1,389 | 1,401 | +10 | +0.7% | 767,400 |
2023/12/11 | 1,388 | 1,403 | 1,383.5 | 1,391 | -2 | -0.1% | 1,234,600 |
2023/12/08 | 1,400.5 | 1,402 | 1,384.5 | 1,393 | -7 | -0.5% | 1,349,400 |
2023/12/07 | 1,394.5 | 1,410 | 1,394.5 | 1,400 | +1 | +0.1% | 960,700 |
2023/12/06 | 1,400 | 1,404 | 1,384 | 1,399 | +13 | +0.9% | 678,700 |
2023/12/05 | 1,407 | 1,409 | 1,385 | 1,386 | -8 | -0.6% | 1,007,300 |
2023/12/04 | 1,392.5 | 1,405 | 1,378 | 1,394 | -28.5 | -2% | 892,000 |
2023/12/01 | 1,422 | 1,434 | 1,412.5 | 1,422.5 | +23.5 | +1.7% | 1,817,200 |
2023/11/30 | 1,392.5 | 1,401.5 | 1,376.5 | 1,399 | ±0 | ±0% | 1,150,100 |
2023/11/29 | 1,396 | 1,399 | 1,379.5 | 1,399 | -9.5 | -0.7% | 1,016,100 |
2023/11/28 | 1,398 | 1,412.5 | 1,393 | 1,408.5 | +23.5 | +1.7% | 1,179,900 |
2023/11/27 | 1,375 | 1,386.5 | 1,370 | 1,385 | +21.5 | +1.6% | 1,123,900 |
2023/11/24 | 1,370 | 1,371 | 1,350 | 1,363.5 | +6 | +0.4% | 1,146,900 |
2023/11/22 | 1,338 | 1,369.5 | 1,330 | 1,357.5 | +20.5 | +1.5% | 1,155,500 |
2023/11/21 | 1,323.5 | 1,340 | 1,291 | 1,337 | +4.5 | +0.3% | 1,682,400 |
2023/11/20 | 1,322 | 1,349.5 | 1,320.5 | 1,332.5 | +2.5 | +0.2% | 1,866,800 |
2023/11/17 | 1,334 | 1,346.5 | 1,312.5 | 1,330 | -1 | -0.1% | 2,188,400 |
2023/11/16 | 1,369 | 1,377 | 1,331 | 1,331 | -57.5 | -4.1% | 1,788,000 |
2023/11/15 | 1,373.5 | 1,405 | 1,373 | 1,388.5 | +4 | +0.3% | 1,641,700 |
201~
250
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 167,200円 | 0.0% | +50.6% | 2.03% | 17.82倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 175,500円 | -3.5% | -50.2% | 4.56% | 14.21倍 | 1.06倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 279,500円 | +18.2% | +4.2% | 1.18% | 19.80倍 | 2.53倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
ツムラ | 482,800円 | +22.6% | +68.1% | 2.82% | 12.86倍 | 1.24倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 428,800円 | +7.3% | -3.8% | 2.10% | 19.91倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
市場注目の銘柄
チャート関連のコラム